1. Home
  2. LKCO vs PTIX Comparison

LKCO vs PTIX Comparison

Compare LKCO & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LKCO
  • PTIX
  • Stock Information
  • Founded
  • LKCO 2009
  • PTIX 1994
  • Country
  • LKCO China
  • PTIX United States
  • Employees
  • LKCO N/A
  • PTIX N/A
  • Industry
  • LKCO EDP Services
  • PTIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LKCO Technology
  • PTIX Health Care
  • Exchange
  • LKCO Nasdaq
  • PTIX Nasdaq
  • Market Cap
  • LKCO 4.3M
  • PTIX 3.7M
  • IPO Year
  • LKCO N/A
  • PTIX 2016
  • Fundamental
  • Price
  • LKCO $1.53
  • PTIX $0.70
  • Analyst Decision
  • LKCO
  • PTIX
  • Analyst Count
  • LKCO 0
  • PTIX 0
  • Target Price
  • LKCO N/A
  • PTIX N/A
  • AVG Volume (30 Days)
  • LKCO 13.9K
  • PTIX 258.9K
  • Earning Date
  • LKCO 12-26-2024
  • PTIX 11-14-2024
  • Dividend Yield
  • LKCO N/A
  • PTIX N/A
  • EPS Growth
  • LKCO N/A
  • PTIX N/A
  • EPS
  • LKCO N/A
  • PTIX N/A
  • Revenue
  • LKCO $10,236,235.00
  • PTIX N/A
  • Revenue This Year
  • LKCO N/A
  • PTIX N/A
  • Revenue Next Year
  • LKCO N/A
  • PTIX N/A
  • P/E Ratio
  • LKCO N/A
  • PTIX N/A
  • Revenue Growth
  • LKCO N/A
  • PTIX N/A
  • 52 Week Low
  • LKCO $1.45
  • PTIX $0.45
  • 52 Week High
  • LKCO $8.00
  • PTIX $1.87
  • Technical
  • Relative Strength Index (RSI)
  • LKCO 34.54
  • PTIX 55.96
  • Support Level
  • LKCO $1.43
  • PTIX $0.50
  • Resistance Level
  • LKCO $1.86
  • PTIX $0.56
  • Average True Range (ATR)
  • LKCO 0.14
  • PTIX 0.06
  • MACD
  • LKCO -0.00
  • PTIX 0.01
  • Stochastic Oscillator
  • LKCO 7.73
  • PTIX 84.31

About LKCO Luokung Technology Corp

Luokung Technology Corp is a spatial-temporal intelligent big data services company, as well as a provider of LBS for various industries in China. It has established city-level and industry-level holographic spatial-temporal digital twin systems and actively serves industries including smart transportation (autonomous driving, smart highway and vehicle-road collaboration), natural resource asset management (carbon neutral and environmental protection remote sensing data service), and LBS smart industry applications (mobile Internet LBS, smart travel, smart logistics, new infrastructure, smart cities, emergency rescue, among others).

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

Share on Social Networks: